OneMedNet Corporation announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD?. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-market surveillance.
This essential data which fuels technology and clinical advancement can sit idle and unproductive without healthcare providers engagement. Importantly, academic tertiary centers also offer significant data diversity which is a high priority for the Food and Drug Administration when reviewing regulatory submissions. The OneMedNet iRWD? network consists of over 200 healthcare systems and providers. The addition of this tertiary medical center expands OneMedNet's carefully compiled RWD to 20 research centers and institutions. The main hospital is ranked in the top 40 nationwide and features one of the leading cancer centers. Given that oncology RWD is of highest demand, this represents a significant OneMedNet network addition.